| The Cancer Genome Atlas Pan-Cancer analysis project TCGA Network, JN Weinstein, EA Collisson, GB Mills, KRM Shaw, ... Nature Genetics 45 (10), 1113–1120, 2013 | 6638* | 2013 |
| Comprehensive molecular characterization of gastric adenocarcinoma TCGA Network Nature 513 (7517), 202-209, 2014 | 5248 | 2014 |
| TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells Mariathasan, Turley, Nickles, Castiglioni, Yuen, Wang, Kadel, Koeppen, ... Nature, 2018 | 3884 | 2018 |
| Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas Cancer Genome Atlas Research Network New England Journal of Medicine 372 (26), 2481-2498, 2015 | 2949 | 2015 |
| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015 | 2727 | 2015 |
| Integrated Genomic Characterization of Papillary Thyroid Carcinoma TCGA Network Cell 159 (3), p676-690, 2014 | 2564* | 2014 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1784* | 2020 |
| Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma TCGA Network Cancer Cell 32 (2), 185-203, 2017 | 1590 | 2017 |
| Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. KA Hoadley, et al. Cell 158 (4), 929-44, 2014 | 1546 | 2014 |
| Emerging landscape of oncogenic signatures across human cancers G Ciriello, ML Miller, BA Aksoy, Y Senbabaoglu, N Schultz, C Sander Nature genetics 45 (10), 1127-1133, 2013 | 1516 | 2013 |
| Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ... Nature, 2017 | 1020 | 2017 |
| Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas TCGA Network Cell 171 (4), 950-965, 2017 | 838 | 2017 |
| Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures Y Şenbabaoğlu, RS Gejman, AG Winer, M Liu, EM Van Allen, ... Genome biology 17, 1-25, 2016 | 810 | 2016 |
| The head and neck cancer immune landscape and its immunotherapeutic implications R Mandal, Y Senbabaoglu, A Desrichard, et al. JCI Insight 1 (17), 2016 | 703 | 2016 |
| Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy CX Dominguez, S Müller, S Keerthivasan, H Koeppen, J Hung, S Gierke, ... Cancer discovery 10 (2), 232-253, 2020 | 553 | 2020 |
| Mitochondrial DNA copy number variation across human cancers E Reznik, M Miller, Y Şenbabaoğlu, N Riaz, J Sarungbam, S Tickoo, ... eLife 5 (e10769), 2016 | 457 | 2016 |
| Multilevel genomics-based taxonomy of renal cell carcinoma F Chen, Y Zhang, Y Şenbabaoğlu, G Ciriello, L Yang, E Reznik, B Shuch, ... Cell reports 14 (10), 2476-2489, 2016 | 346 | 2016 |
| Critical limitations of consensus clustering in class discovery Y Senbabaoglu, G Michailidis, JZ Li Scientific Reports 4, 2014 | 322 | 2014 |
| Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival L Morris, N Riaz, A Desrichard, Y Şenbabaoğlu, A Hakimi, V Makarov, ... Oncotarget, 2016 | 296 | 2016 |
| CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours R Zappasodi, I Serganova, IJ Cohen, M Maeda, M Shindo, ... Nature 591 (7851), 652-658, 2021 | 253 | 2021 |
Chris SanderHarvard Medical School, Broad Institute, Dana-Farber Cancer Institute, Memorial Sloan Kettering在 sanderlab.org 的电子邮件经过验证
